BioSpace News Archive

Fund raising Capital Donation. Funds Support Concept. Fundraising. Collecting donations in jar.

Funding

Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation

The Novo Nordisk Foundation’s funds will go toward supporting early-stage companies working in “human health, planetary health and societal resilience.”

January 16, 2026

·

2 min read

·

Tristan Manalac

Art collage, hands and scales of justice. The concept of the law of the judge.

Legal

Former Emergent CEO Hit With Insider Trading Lawsuit

Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with information related to the company’s manufacturing operations that had yet to be made public.

January 16, 2026

·

2 min read

·

Tristan Manalac

Contemporary art collage of human hands holding a arrow pointing up, graphs and diagrams. Concept of profit, making money, business. Copy space.

Mergers & acquisitions

Speculation of Sanofi Takeover Sends Ocular’s Stock Soaring

Ocular Therapeutix’s lead asset is Axpaxli, being developed for wet age-related macular degeneration. A Phase III study is underway, with data expected this quarter.

January 16, 2026

·

1 min read

·

Tristan Manalac

Illustration showing finger pointing people to leave

Layoffs

Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug

Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of the Cambridge, Massachusetts–based biotech’s workforce is being cut while most of the rest are furloughed.

January 16, 2026

·

2 min read

·

Angela Gabriel

Business

JPM26: Protagonist Has a $400M Decision To Make. It’s a No-Brainer

Following rusfertide’s triumphant Phase III trial last year, Protagonist must decide how involved to be in future development. Hundreds of millions of dollars are on the line.

January 16, 2026

·

2 min read

·

Annalee Armstrong

Top view of successful businessman lost in labyrinth

RNA editing

JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position

After a cacophony of troubles hit the RNA editing biotech last fall, CEO Ram Aiyar is in San Francisco to develop partnerships, pitch the potential of its new AATD program and find more money to keep the dream alive.

January 16, 2026

·

3 min read

·

Dan Samorodnitsky

Paper airplanes flying on blue sky and cloud.Paper art style of business teamwork and one different vision creative concept idea.Vector illustration

Mergers & acquisitions

JPM26: Deal Hungry Novo Moves With ‘Intention’ To Put Metsera in the Rearview

Speaking on the sidelines of the J.P. Morgan Healthcare Conference, Novo business development executive Tamara Darsow said the company is gunning for obesity and diabetes assets.

January 16, 2026

·

3 min read

·

Annalee Armstrong

Press Releases

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

January 16, 2026

·

9 min read

Press Releases

First Patients in the UK Receive Doses of Blue Earth Therapeutics’ Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate Resistant Prostate Cancer